Section divider

Increasing the population’s access to lifesaving health care since the late 1980s.

  • The Services de Santé à Grand Impact project recorded over 1.3 million new family planning users over the past five years, with 32% of users adopting long-acting methods. To reach this many clients, Jhpiego trained more than 1,000 providers in over 500 facilities across the four project regions on family planning technical skills, including how to insert contraceptive implants, IUDs and postpartum IUDs.
  • As a result of Jhpiego’s capacity building, the number of health centers offering basic emergency obstetric and newborn care increased from 47 to 238 facilities, and 54 health centers being capable of offering more advanced comprehensive care.
  • In 2019, Jhpiego supported the government of Mali to develop and implement cutting-edge self-injection national guidelines for a new form of contraception, depot-medroxyprogesterone acetate (DMPA-SC), thereby increasing Malian women’s access to a modern comprehensive method mix.

Our Work in Mali

As a partner to Save the Children on this U.S. Agency for International Development-funded program, Jhpiego provides technical leadership on maternal and newborn health, malaria in pregnancy, family planning (FP) and quality improvement of health care services. Working in four regions and 36 districts, the program is building the capacity of providers to improve antenatal care (including intermittent preventive treatment of malaria) and maternity services (including management of obstetric and newborn complications) at designated health care facilities. To expand access to FP services, Jhpiego is helping to improve service delivery and FP method mix in public health care facilities by increasing the availability of long-acting reversible contraception; these efforts include task shifting by training matrones (or trained birth attendants) to insert contraceptive implants. Capacity building for FP also includes integration of FP services with maternity care to reach women with information about postpartum FP options during antenatal care visits and immediately following delivery. Given comparatively high rates of antenatal care attendance and delivery in health care facilities (as compared to FP consultations), this is a key opportunity to reach women with FP information and methods for healthy timing and spacing of pregnancies. In addition, the program has trained selected providers on management of postabortion care, along with FP counseling and provision of long-acting reversible contraception services, and supports annual national FP campaigns to generate awareness and interest in FP.

Impact Malaria is a global project of the U.S. President’s Malaria Initiative to reduce mortality and morbidity caused by malaria. Implemented by a consortium of organizations led by PSI, the project is funded by the U.S. Agency for International Development. In close collaboration with the country’s National Malaria Control Program, other sections of the Ministry of Health and various implementing partners, Impact Malaria is designed to improve malaria service delivery via the following objectives: 1) improve the quality of and access to malaria case management and prevention of malaria in pregnancy; 2) improve the quality of and access to other malaria drug-based approaches and provide support to pilot/scale up newer malaria drug-based approaches; and 3) provide global technical leadership, support operational research and advance program learning.

Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is working closely with the Access Collaborative to strengthen health systems to accelerate introduction and scale-up of DMPA-SC in eight West African countries, including Mali.

Funded by the Clinton Health Access Initiative, Jhpiego is working closely with Mali’s Ministry of Health to rapidly expand comprehensive trainings of health care providers around Bamako on a new contraceptive, depot-medroxyprogesterone acetate (DMPA-SC). These trainings are in line with the Jhpiego-supported, recently adopted National Scale-Up Plan for DMPA-SC, including the national guidelines on self-injection.

With funding from the Bill & Melinda Gates Foundation, Jhpiego is developing an ANC/PNC innovations and implementation research platform. This initiative is designed to strengthen ANC/PNC service delivery through implementation research in Ethiopia, Malawi and Mali, and to disseminate learnings globally. The primary expected outcomes include earlier entry by pregnant women into ANC/PNC care; increased continuity of care; improved quality of care; and an improved understanding of key risk factors, vulnerabilities and morbidity/mortality outcomes. The research collective unifies multiple teams under a single collective, comprised of the following partners: Jhpiego, Harvard School of Public Health, Child Health and Mortality Prevention Surveillance (CHAMPS), RTI International, Christian Medical College Vellore, DAI, the World Health Organization, CARE/India and the University of Manitoba. As part of this collective, Jhpiego is: 1) conducting implementation research on innovative service delivery models and tools in three countries; 2) serving as technical advocacy lead by synthesizing data and findings across the collective to inform an evidence package; and 3) providing technical assistance, as needed, as collective partners conceptualize, design, implement and test new service delivery models. Jhpiego is also partnering with the Johns Hopkins School of Public Health Biostatistics Center and Department of International Health for support with statistical analysis, data management and implementation research design.